RxDoctor Payments Data

Assia Bromberg

Internal Medicine · Fair Lawn, NJNPI 1629047261

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 241 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by GSK at 26.9% of the total.

$4,840in general payments, 2019–2025

Across 241 payments — averaging $20.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$1K
  • AstraZeneca$1K
  • AbbVie$971
  • Boehringer Ingelheim$258
  • Merck$241
  • Mylan Specialty L.p.$236
  • plus $668 from 15 others

What the payments were for

  • Food & beverage$4,840100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,840 in reported general payments places this provider in the 85th percentile of 4,032 internal medicine providers in New Jersey.

See all internal medicine providers in New Jersey →

Other internal medicine in Fair Lawn

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →